American Century Companies’s Avadel Pharmaceuticals AVDL Stock Holding History

American Century Companies's AVDL Position: Q1 2026 in Review

American Century Companies sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 10,936 shares — an estimated $236K sold.

American Century Companies first reported a position in AVDL in Q4 2025 and held it in 1 quarter. The position peaked at $236K in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

• American Century Companies reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
• American Century Companies sold 10,936 Avadel Pharmaceuticals shares in Q1 2026, an estimated $236K.
• American Century Companies first reported a position in Avadel Pharmaceuticals in Q4 2025 and held it in 1 quarter.
• American Century Companies's Avadel Pharmaceuticals position peaked at $236K in Q4 2025.
• 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.